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Abstract
Dengue fever is a fatal vector transmitted disease and is one of the most significant 
health problems which have magnified its impact globally by afflicting 390 million 
people across 110 countries. The causative agent of this life-threatening disease is a posi-
tive single-stranded RNA arbovirus known as dengue virus (DENV), which uses Aedes 
aegypti mosquito as an intermediate host. It has been well demonstrated that virus evades 
mosquito’s RNA interference (RNAi)-mediated antiviral defense and manipulates host 
microRNA (miRNA) profile to its own benefit. However, the exact mechanisms are still 
not exclusively elucidated. The molecular mechanisms which characterize the role of 
novel DENV-encoded small RNAs and other viral proteins in host miRNA modulation 
and evasion of RNA interference are still elusive. Furthermore, the possibility of small 
activating RNAs-(RNAa)-mediated activation in mosquitoes in conjunction with dengue 
virus genes is not fully explored. This book chapter pragmatically overviews intricate 
interplay between virus-host interactions, how virus invades host antivirus defense 
mechanisms, and possibly the potential emerging therapeutic role of RNA activation 
(RNAa) and RNAi for the infections, which can be cured by specific gene activation and 
gene silencing, respectively.
Keywords: dengue fever, dengue fever virus, Aedes aegypti, RNA interference, 
microRNAs, RNA association, host-virus interaction, DENV therapy
1. Introduction
Dengue virus (DENV) is a major arbovirus that uses Aedes aegypti mosquitoes as an intermediate 
host to be transmitted to human and is the causative agent of most serious mosquito-borne viral 
disease (i.e., dengue fever) afflicting around more than 390 million people worldwide [1]. Despite 
substantial efforts to control dengue virus vector, it is still emerging rapidly [2]. Therapeutic 
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options are limited as the available treatments are just supportive, and there is no specific 
therapy or approved vaccine available. DENV belongs to Flaviviridae family, which comprises 
lipid-enveloped, positive-sense single-stranded RNA viruses [3]. DENV is classified into four 
closely related serotypes based on antigen distinction and represented as DENV-1 to DENV-4. 
The length of DENV genome is 10.7 kilobases comprising a single open reading frame (ORF) 
flanked by highly conserved 5′ and 3′ nontranslated regions. Single ORF encodes a polyprotein 
of approximately 3391 amino acids, which is further processed by host (furin and signalase) and 
viral proteases (NS2B/NS3 protease complex) to generate three structural (C, prM, and E) and 
seven nonstructural genes (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) [4, 5].
RNA interference (RNAi) is evolutionarily conserved phenomenon, constituting a major com-
ponent of mosquito innate immune response to virus infections [6]. It has been demonstrated 
that dengue virus elicits RNAi response in Ae. aegypti but is unable to completely repress viral 
replication instead it may just modulate virus replication to maintain persistent viral infec-
tion to ensure long-term survival of infected mosquitoes [7]. It has been explored that DENV 
employs two different mechanisms to inhibit RNAi pathway, involving RNAi suppression 
protein NS4B and subgenomic flavivirus RNA (sfRNA). Dengue virus encoded nonstructural 
protein, NS4B, has been reported to suppress RNAi pathway in both human Huh-7 cells by 
the mechanism still not fully understood [8]. Furthermore, dengue virus infection produces 
3’ NTR degradation product sfRNA that is thought to incapacitate RNAi pathway by inhibit-
ing dicer-mediated cleavage of dsRNA [9]. Recently, it has been ferreted out that in Culex 
mosquitoes, West Nile virus (WNV) replication is repressed by cytokine-like secreted antivi-
ral protein “vago” in a dicer-2-dependent manner [10]. However, the possible effect of vago 
protein against dengue virus replication in Ae. aegypti research area is not explored yet. Such 
evidence clearly indicates that dengue virus opts variety of mechanisms to evade mosquito 
immune response to successfully replicate in the mosquitoes.
Apart from small interference RNAs (siRNA) reputation to inhibit gene expression through 
a phenomenon called RNAi, the target gene can also be induced by a mechanism called 
RNA activation (RNAa). The term RNAa was first coined by Li, who named them after he 
surprisingly found up regulation of human E-cadherin, p21, and VEGF genes by synthetic 
dsRNAs designed to target promoters of these genes [11]. He further named those promoters 
targeting small RNAs as short activating RNAs (saRNAs). Recent studies in which authors 
evaluated RNAa of above-said genes in monkey, rat, and mouse found that RNAa is highly 
conserved among all mammals [12]. However, the term RNA activation is not necessarily lim-
ited to transcriptional activation by saRNA, targeting promoter region only, rather it should 
be used to describe all small RNA-mediated gene and epigenome activation mechanisms, 
including transcriptional activation by targeting 3′ terminal regions of genes with saRNAs 
[13], piwi-interacting RNA (piRNAs)-mediated epigenetic activation [14], and microRNA 
(miRNA)-mediated translation activation [15]. One of the key differences between RNAi and 
RNAa is their kinetics. RNAi effect is known to occur within a couple of hours and disappears 
5–7 days following siRNA transfection, while RNAa effect does not appear until about 48 h 
posttransfection and lasts much longer (at least 2 weeks) [16]. This delay may be due to the 
more complex mechanism of RNAa involving nuclear access and chromatin restructuring as 
compared to RNAi [17].
Current Topics in Tropical Emerging Diseases and Travel Medicine94
microRNAs (miRNAs) represent one of the shortest functional classes of noncoding RNAs, 
depicting hottest spot of gene regulation research. They were first reported in 1993 in small 
round worms Caenorhabditis elegans [18]. Since then, miRNAs have been implicated in 
regulating all cellular pathways in eukaryotes ranging from development to oncogenesis. 
These 20–24 nucleotide-long noncoding RNAs have been demonstrated to be encoded by 
a diverse range of organisms including plants, humans, insects, and even viruses [19]. The 
miRNA shows a very high degree of evolutionary sequence conservation among species 
[20] proved by the presence of miRNA biogenesis complex in archaea and eubacteria [21]. 
Historically, these microRNAs were thought to regulate different gene expressions either 
by degradation of particular mRNA or inhibition of translation [22, 23]. However, recent 
studies have revealed that these small noncoding RNAs can also activate the target gene 
expression through mRNA stabilization [15, 24]. As the molecular biology, bioinformatics 
approaches and protocols of small RNA sequencing continue to grow and sophisticate, so is 
the number of miRNAs discovered in different species. It is becoming more and more appar-
ent that miRNAs not only constitute a fundamental part of regulatory machinery but also 
may act as molecular decoys to interfere with the function of regulatory RNA-binding pro-
teins [25]. miRNA is involved in fundamental physiological and pathological processes like 
cancer development and host-pathogen interactions [26–29]. The pathogens have evolved 
to use to host machinery by altering the expression level of host miRNAs for their benefit 
[30]. Furthermore, microorganism-encoded miRNAs have also been reported to vary the host 
gene expression to their advantage [30]. Despite recent advances, there are still significant 
gaps in our understanding of miRNAs role in host-pathogen interactions, which is probably 
due to lack of miRNA characterization.
This pragmatic book chapter overviews the possibility of RNAi suppressor activity of DENV 
in the context of different viral genes. By characterizing the role of different DENV genes in 
RNAi suppression, we will review to gather valuable lead into the mechanism that governs 
DENV RNAi evasion in mosquitoes and the viral genes that are responsible for it. We will 
also explicit the possibility of RNA activation (RNAa) in insect, especially mosquitos. It is 
interesting to characterize whether RNAa has any role in host pathogen interaction because, 
despite the difference in their mode of action, RNAa use same RNAi machinery to induce 
gene activation. Although very few virus-encoded miRNAs have been fully characterized, it is 
understandable that they can target both viral and host genes. The information will produce a 
better understanding of microRNAs role in DENV replication and further deeper insight into 
characterization of DENV-mediated differential expression of Ae. aegypti miRNAs.
2. Dengue virus genome organization
The dengue virus (DENV) genome comprises a single open reading frame (ORF) of approxi-
mately 10.7 kilobases flanked by 5′ and 3′ nontranslated regions (NTRs) [30]. The nontrans-
lated regions contain highly conserved secondary structures and coding regions in ORF, 
which play integral roles in viral life cycle. The composition of secondary structures is based 
on the sequencing of DENV-2 (a southeast Asian strain) strain, which is similar to other 
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different viral strains and serotypes. Although most of the DENV proteins are with known 
functions but some remains to be explored (Table 1) [31].
3. Viral entry
DENV is mostly introduced in human by infected Ae. aegypti mosquitoes. After the introduc-
tion, DENV particularly targets mononuclear phagocyte lineage cells including the skin resis-
tant Langerhans cells [31, 32]. However, in mosquitoes, DENV is thought to initially target 
midgut and then extends and replicate in other peripheral tissues [33]. DENV can infect a 
very diverse range of cell lines including human, mosquito, monkey, hamster, and murine 
cell linages. This suggests that either DENV uses a ubiquitous receptor or it uses multiple 
receptors for its entry [33]. In mosquito cells, different independent groups have reported 
many potential DENV receptors like heat shock protein 70 (HSP), R80, R60, and 45 kDa pro-
tein [33]. In human beings, heparan sulfate [34], Hsp90 [35], CD14 [36], GRP78/BiP [37], and 
a 37/67-kDa high-affinity laminin receptor have been reported [38]. DENV particles interact 
with human myeloid cells by C-type lectin receptors (CLR) including DC-specific intracellu-
lar adhesion molecule 3 (ICAM-3)-grabbing no integrin (DC-SIGN, CD209) [39, 40], mannose 
receptor (MR), and C-type lectin domain family 5, member A (CLEC5, MDL-1) [41].
Table 1. Functions of DENV genome structural and nonstructural proteins.
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4. Viral replication
DENV like other flaviviruses, after adsorption to receptors, is endocytosed by cells in clathrin-
dependent manner and then is further transported to endosomes [42]. However, according to 
one study, DENV can adopt clathrin-independent pathways as well to gain entry into mam-
malian cells in particular [43]. DENV nucleocapsid is released into cytosol after acidic pH trig-
gered rearrangements of envelope protein in late endosomes leading to fusion of viral envelope 
and cellular endosome membrane [44, 45]. The nucleocapsid disassembles, and viral genome 
is translated by endoplasmic reticulum (ER)-located ribosomes generating numerous copies 
of viral proteins. NS5 and other viral nonstructural proteins along with various host proteins 
establish replication complexes [46]. At replication complex, the viral polymerase (NS5) tran-
scribes negative viral RNA, which serves as a template for synthesis of subsequent positive 
viral RNA copies. Viral replication is regulated by 5′-3’ UTR sequences (upstream of AUG 
region) present in 5′-3’ UTRs, which are actively involved in the circularization of DENV RNA 
[47]. These newly synthesized positive DENV RNAs interact with core proteins to assemble 
into nucleocapsids [48]. The nucleocapsid buds into ER lumen, thereby getting enveloped in a 
membrane bilayer carrying the viral prM and E proteins [46]. From ER lumen, immature viral 
particles are transported through cellular secretary pathways, furin protease cleaves prM, and 
results in the formation of mature viral particles capable of infecting naïve cells [49].
5. Virus-host interactions
In nature, almost every organism engages in ecological or molecular interactions whether 
antagonistic or mutualistic with other organisms of different species to thrive and excel. 
These interactions are major drivers of diversification and adaptive evolution. Among these 
interactions, most fascinating examples are those involved in invertebrate susceptibility to 
pathogens [50]. According to a recent study, the susceptibility of Ae. aegypti to dengue virus 
has a genetic basis for genotype-by-genotype interactions [51]. It is evident by the fact that 
despite pathogenic nature of dengue virus in human, its interaction with Ae. aegypti mosquito 
is somehow mutualistic. DENV has somehow improvised to overcome mosquito defenses 
and manipulate its cellular machinery in a way still not well known that emancipates its 
replication without interfering too much with normal growth of mosquitos.
6. RNA interference (RNAi)
RNA interference (RNAi) is a major component of innate defense of invertebrates against patho-
gens. Most arboviruses cause persistent infections within their arthropod vectors. However, 
how viruses maintain persistent infection in the face of a robust RNAi response is still not fully 
understood. Many plants and animal viruses have evolved molecular mechanisms for subvert-
ing the host RNAi response. For example, Flock house virus (FHV) encodes B2 protein, which 
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directly binds to dsRNA to inhibit DCR2 activity, to inert siRNA pathway [52]. In another 
study, researchers have found that plasmid-expressed La Crosse virus (LACV) NSs protein 
successfully inhibits interferon (IFN) and RNAi pathway in mammalian cells and mice, while 
fails to show any RNAi-suppressive effect in transfected U4.4 cells and C6/36 cells infected 
with LACV [53]. A recent publication has revealed that DENV NS4b functions as an RNAi 
suppressor in human Huh-7 cells via inhibition of dsRNA processing by Dicer [8]. However, 
whether NS4b behaves similarly in mosquitoes has not been investigated, and to date, no RNAi 
suppressor activity has been described for an arbovirus protein during mosquito infection. 
Given that DENV successfully develops persistent infection in mosquitoes despite their RNAi 
response, the precise mechanism of RNAi evasion is definitely a significant point of interest.
7. RNA activation (RNAa)
RNA activation (RNAa) is one of the nascent phenomena around the scientific field. RNAa is 
considered to be a potent emerging therapeutic strategy for the disease that can be cured by 
particular gene activation [54]. However, most of the studies relating to RNAa research have 
been carried out in human cell line. Till date, proper mechanism of RNAa is still not clear. 
However, it has been demonstrated that it is mostly a nuclear event that leads to chromatin 
restructuring [17]. RNA activation is still in its infancy, so its exact mechanism is still elusive. 
Recently, Portnoy et al. has proposed a model for the promoter-directed-small-activating-
RNA (saRNAs)-mediated RNA activation. In this model, authors proposed that an exog-
enously introduced saRNA or endogenously produced small noncoding RNA, (e.g., miRNA) 
is loaded into an Ago protein in the cytoplasm. The Ago protein processes the saRNA by dis-
carding its passenger strand to form an active Ago-RNA complex. Ago-RNA complex enters 
the nucleus through active transport/passive diffusion cell division. Guide strand directs Ago-
RNA complex to complementary genomic DNA sequences usually in promoter region or to 
noncoding RNA (ncRNA) sequences, which tethers to the DNA. After that, the Ago-RNA 
complex initiates a process that differs from RNAi, which alter chromatin structure and epi-
genetic states of target gene via two different potential mechanistic models. In model A, the 
saRNA guide strand leads the Ago protein to its DNA target by constituting an RNA–DNA 
duplex or triplex structure, while Ago protein then serves as a docking platform to attract 
histone-modifying activities, like opening of chromatin structure and active transcription. On 
the other hand, in model B, the RNA guide strand binds to cognate promoter transcripts mak-
ing saRNA-RNA complex and then Ago protein recruits histone modifiers to introduce active 
chromatin marks on local chromosome, resulting in activation of transcription [17].
8. MicroRNAs (miRNAs)
As the molecular biology, bioinformatics approaches and protocols of small RNA sequencing 
continue to grow and sophisticate, so is the number of miRNAs discovered in different species. 
Virus-encoded miRNAs have been known to be crucial for the viral replication. miRNAs encoded 
by DNA viruses have been well studied in comparison with those by RNA viruses because RNA 
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viruses lack nuclear access [55]. However, recent discovery of noncanonical miRNA biogenesis 
pathways that utilize Argonaute (Ago) 2 for processing of pre-miRNA to mature miRNA has 
highlighted the fact that RNA viruses may opt similar pathway to generate functional miRNAs. 
Similar noncanonical pathways might be used to generate functional miRNAs derived from 
RNA viruses that replicate in the cytoplasm. Several examples up to now have been accumulated 
like cellular miRNAs, miR-124, is expressed from a cytoplasmic RNA virus, Sindbis virus (SINV) 
[56]. Several miRNAs were found to be produced by a retrovirus, Bovine leukemia virus (BLV), 
based on DNA polymerase III transcription in vivo as well as in vitro [57]. Recently, Hussain et al. 
have identified six DENV-encoded miRNA like small RNAs in which one of miRNAs directly 
targets DENV NS1 gene during late infection to autoregulate its replication. Functional analysis 
has revealed that viral miRNAs can target both cellular and viral mRNAs to regulate viral rep-
lication leading to a successful infection [58]. Although, very few virus-encoded miRNAs have 
been fully characterized, it is understandable that they can target both viral and host genes.
Flaviviruses are well reported to manipulate host miRNA machinery to facilitate their rep-
lication. It has been well reported that DENV induce differential expression of miRNAs in 
human peripheral blood mononuclear cells (PBMCs) [59]. It has been previously reported 
that miR-124a, -128a, -218, and -let-7c may be important for neurological symptoms caused by 
a chimeric tickborne encephalitis/dengue virus [60]. Additional studies have shown that miR-
122 and miR-142 of the host cells are involved in restricting dengue virus [61, 62]. However, 
most of the above work has been done in human. Very little is known about the differential 
miRNA expression of Ae. aegypti influenced by DENV infection, leaving a significant gap in 
our understanding of DENV-Aedes aegypti interaction. Although a recent study has shown 
aberrant host small RNA (sRNA) profiles in Ae. aegypti during DENV infection, it mainly 
focused on piRNAs [63] leaving a significant gap in understanding the differential expression 
of Ae. aegypti miRNAs during DENV replication.
9. miRNA biogenesis
9.1. miRNAs genomic arrangement and transcription
miRNAs are usually encoded by different regions of genome ranging from coding as well as 
noncoding [64]. Seventy percent of mammalian miRNAs are the intron products of protein 
coding genes, while rest comes from the noncoding transcription units. miRNAs have been 
found to be originated from both senses and antisense strands of DNA [65]. Studies have 
shown that about 30% of C. elegans miRNA genes are on the antisense strand overlapping 
protein coding region [66]. In Drosophila too, many miRNAs are originated from antisense 
strand overlapping protein coding region [67]. Multiple miRNAs can be transcribed as one 
long transcript named clusters [18].
Majority of miRNAs are transcribed by RNA polymerase II; however, some miRNAs usually 
located near Alu repeats are transcribed by RNA polymerase III, from independent genes 
having their own promoter or represent introns of protein-coding genes [18]. Nearly, all the 
independent miRNA promoters have particular features of Pol II promoters, including initia-
tor elements and TATA boxes [18].
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9.1.1. Canonical pathway of miRNA biogenesis
So far, a vast majority of reported miRNAs are produced through an RNase III enzyme-controlled 
canonical pathway. Transcription of primary transcript (i.e., pri-miRNA) harboring one or sev-
eral stem loop structures by RNA polymerase II or otherwise RNA polymerase III kick start the 
biogenesis process in nucleus [68, 69]. pri-miRNAs are then further processed at stem loop sites 
by two RNase III proteins Drosha and DGCR8/Pasha (DiGeorge critical region 8) to produce 
about 70 nucleotide pre-miRNA [70]. This pre-miRNA is then exported to cytoplasm with the 
help of exportin-5 and RanGTP proteins [71]. Once in cytoplasm, pre-miRNA is chopped down 
into 22 nucleotide miRNA duplexes. Apart from above-mentioned proteins, many other pro-
teins also work as cofactors to influence the outcome of miRNA biogenesis [65, 72].
9.1.2. Noncanonical pathway of miRNA biogenesis
Although, it was thought earlier that there is only one universal mechanism of all mature 
miRNAs biogenesis; however, multiple recent discoveries have led us to the conclusion 
that there may be several other miRNA biogenesis pathways as well. Biogenesis of quite 
a few miRNAs has been demonstrated to be not only Drosha independent, but also Dicer 
dependent [73]. It has been reported that in Drosophila and C. elegans along with some 
other vertebrates, mature miRNAs called “mirtrons” can be produced after splicing from 
intron hairpins independently of Drosha processing [74–76]. Recent studies have revealed 
that mature functional miRNAs can arise from highly conserved small nucleolar RNA 
(snoRNAs) in human and Giardia lamblia [77, 78] as well as DicerII-processed endogenous 
siRNAs mostly derived from transposable elements and load into AgoI in Drosophila [76]. 
Furthermore, researchers have identified miRNAs derived from transfer RNA (tRNA) in 
mouse embryonic stem cells [79].
Recent studies have led to the discovery of other types of miRNA noncanonical biogenesis 
pathway that is Dicer independent. One prime example of this is miR-451 biogenesis, which 
is Dicer independent as pre miR-451 has ~18 nucleotide stem duplex that is too short for 
Dicer activity. However, pre miR-451 requires AgoII for its maturation [80]. A few examples 
of other types of noncanonical biogenesis come from virus-encoded miRNAs. For example, 
several miRNAs are produced by a retrovirus, Bovine leukemia virus (BLV), based on DNA 
polymerase III transcription in vivo as well as in vitro [57]. The products of these transcripts 
were too small to be recognized by Drosha; therefore, these were directly processed by Dicer-1 
to mature miRNAs.
10. Mode of action of miRNAs
After the production of mature miRNA by either canonical or noncanonical pathway, the 
resulting mature miRNA duplex is loaded into miRNA inducing silencing complex (miRISC) 
having Ago as core component [81]. After degradation of one strand, other strands of duplex, 
representing mature miRNA, then guide miRISC complex to target mRNA to determine its 
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fate [82]. The stability of the base pairs at the ends of the strands of miRNA duplex usually 
determines which strand will be degraded. Usually, less stable strand avoids degradation [82]. 
There are different modes of action of miRNAs that influence the expression of target gene 
ranging from mRNA degradation, translational repression to activation of transcription [16, 
83, 84]. Whatever the outcome is, the general way of miRNA-mRNA interaction relies on the 
sufficient sequence complementarity between mRNA and 5′ seed region (usually 2–8 nucleo-
tides) of miRNA [85]. Perfect complementarity between mRNA and miRNA is likely to down-
regulate the expression of target gene through its mRNA degradation by endonuclease activity 
of miRISC complex. This type of miRNA-mediated gene regulation is mostly evident in plants 
[86]. However, in animals, there is mostly imperfect complementarity between mRNA and 
miRNA, which usually leads to translational repression of target gene [86]. Interestingly, there 
are solid experimental evidences that miRNAs are also involved in upregulation of target 
genes as well. One of its well-characterized examples is host miR-122-mediated upregulation 
of HCV RNA replication by stabilizing HCV RNA and preventing its decay [87].
11. Virus-encoded miRNAs
As most viruses need host genes to facilitate their replication, one cannot rule out the possibil-
ity of viruses encoding miRNAs in order to manipulate host gene expression or keep viral 
copy number under check to ensure persistent infection. Possible benefits of virus-encoded 
miRNAs are that they usually do not elicit immune response, require less coding ability, and 
they have ability to constantly evolve to target new transcripts. Till date, more than 200 viral 
miRNAs have been identified. Most of the well-characterized viral-encoded miRNA comes 
from DNA viruses as compared to RNA viruses, with herpes viruses as a major contribu-
tor having average copy number of more than 10/genome [58]. Different recent studies have 
identified novel microRNAs from different RNA viruses. Bovine leukemia virus (BLV), a ret-
rovirus, also encodes microRNAs [57]. Hussain et al. has reported microRNA like small RNAs 
in both West Nile virus and Dengue virus [88]. These viral-encoded miRNAs are produced 
through canonical as well as noncanonical biogenesis pathways. Based on their function, viral 
encoded miRNAs can be classified into two broad classes:
i. Virus-encoded miRNA regulating host genes
ii. Virus-encoded miRNAs regulating virus copy number
Important functions of viral miRNAs, which target host genes, include promoting cell sur-
vival through downregulation of apoptotic factors, thus promoting infected cells survival 
and proliferation, as well as modulating the immune response of the host cell [89]. It is 
becoming increasingly evident that one mechanism the viruses have evolved to facilitate 
regulatory control over their hosts is by generating transcripts, which outmatch cellular miR-
NAs. Interestingly, Human Kaposi’s sarcoma-associated herpes virus (KSHV) and chicken 
oncogenic Marek’s disease virus (MDV) transcribe miR-K12-11 and miR-M4, respectively; 
these miRNAs appear to be an ortholog of miR-155 to identical seed region [90, 91]. miR-155 
has been reported to be involved in many malignancies [92], so exploitation of its targets by 
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viruses may contribute to viral oncogenesis. Recently, it has been reported that a flavivirus 
named West Nile virus encode an miRNA KUN-miR-1 that specifically induces the expres-
sion of GATA4 in Ae. albopictus that in turn facilitates the WNV replication [88].
Interestingly, virus-encoded miRNAs can regulate their own replication as well their own 
benefit. For example, simian virus 40 (SV40)-encoded miRNA miR-S1, expressed during late 
infection, has been shown to downregulate viral T-antigen, which is crucial to evade cytotoxic 
T cell response [93]. Another example is HvAV-miR-1 encoded by Heliothis virescens ascovirus 
(HvAV), an insect with dsDNA virus that downregulate viral replication by targeting viral 
DNA polymerase I [94]. Recently, it has been reported that Dengue virus (DENV)-encoded 
miRNA like viral small RNA DENV-vsRNA-5 plays an important role in the autoregulation 
of DENV replication by directly targeting dengue virus NS1 protein during late infection [30].
12. miRNA role in host-viral interactions
Regulative control of miRNAs over gene expression in every organism is the core reason why 
pathogens try to hijack them. This takeover may include disruption of miRNA biogenesis 
pathway, inhibiting a specific host miRNA that hinders pathogen propagation or differential 
miRNA expression. In case of human, it has been well documented that miR-146 and miR-
155 are involved in upregulating immune function in response to various bacterial infections 
including H. pylori [95] and Salmonella enterica [96]. Many viruses encode miRNAs, having 
the potential to not only the viral genomes, which encode them, but also to target host tran-
scripts, which facilitate their replication [97, 98]. Functions of viral miRNA targeting host 
genes include cell survival through downregulation of apoptotic factors as well as modula-
tion of host immune response [89]. One example is upregulation of GATA4 by WNV-encoded 
miRNA, which has been found to be very important in virus replication in mosquito cells [88]. 
Recently, it has been demonstrated that viruses have evolved to encode miRNAs that mimic 
host miRNAs. Kaposi’s sarcoma-associated herpes virus (KSHV) encoded miR-K12-11 that is 
an ortholog of human miR-155 sharing same seed region homology that will likely be able to 
regulate all targets of miR-155 [90].
12.1. miRNA role in Aedes aegypti with an insect-specific flavivirus
Previous studies demonstrated that mosquito miRNAs could be affected by different viral 
infections. However, those studies were restricted to pathogenic viruses, mainly restricted to 
the role of differently expressed miRNAs with limited characterization. Limited knowledge 
is available about the modulation of host miRNAs with respect to insect-specific flaviviruses 
(ISFs, e.g., Palm Creek virus (PCV)). ISFs share the similar genome organization with other 
flaviviruses; however, their rate of vertical transmission between insect hosts is higher than 
other vertebrate-infecting flaviviruses. Although it is still unclear that why ISFs fail to replicate 
in mammalian cells, it is assumed that ISFs potentially lack to antagonize the host interferon 
system. Similarly, ISFs express a high adaptation level in insect hosts, which may further 
limit their replication in vertebrate hosts. Recently, Lee et al. explicated the potential role 
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of miRNAs in Palm Creek virus (PCV) infection using the Ae. aegypti mosquito model [99]. 
They proposed differently expressed miRNAs after combining small-RNA sequencing and 
bioinformatics tools although the results hardly predicted the potential involvement of PCV 
infection to alter host miRNAs. They revealed that only one miRNA (i.e., aae-miR-2940-5p) 
out of 101 reported miRNAs of Ae. aegypti that had significantly altered expression over the 
course of PCV infection. The level of aae-miR-2940-5p was induced within 2 days p.i. and sup-
pressed at 12 days p.i.; however, a different pattern of miRNA screening was demonstrated 
in Ae. aegypti Aa20 cell line without displaying any significant change upon PCV infection. 
Further in vitro miRNA inhibition experiments while using aae-miR-2940-5p inhibitors dem-
onstrated that this miRNA did not directly impact on PCV replication and has no significant 
role in PCV-Ae. aegypti interaction. This variable response to virus infection in cell lines and 
host mosquito might be due to tissue tropism of the virus. At mRNA target level, the study 
reported the inconsistent expression level of MetP with miR-2940-5p expression although 
previously it was reported a potential target of aae-miR-2940-5p with positive interaction. It 
means that there was no correlation of MetP expression to PCV infection because silencing the 
gene did not significantly affect the virus replication. The pair MetP--aae-miR-2940-5p also 
positively regulate West Nile virus (WNV) virion production where aae-miR-2940-5p was 
selectively downregulated upon WNV infection in infected cells. The MetP human ortholog 
like M41 ftsh, YME1L, plays an important role as an antiapoptotic factor. It is assumed that the 
induction of aae-miR-2940-5p in PCV-infected cells during infection boosts MetP transcript 
levels and thus protects infected cells undergoing apoptosis under stress responses. However, 
the MetP physiological role is still uncertain in insects and requires further investigation [99].
13. RNA interference in Aedes aegypti with an insect-specific 
flavivirus
RNA interference is considered a vital antiviral defense response in mosquitoes as lot of 
studies reported the production of viral-specific small RNAs for different viruses. However, 
several reports also confirm the establishment of persistent viral infection only in mosquitoes 
either infected by pathogenic mosquito-borne viruses or insect-specific viruses that produce 
these small RNAs. While doing so, viral-derived DNA (vDNA) is produced by reverse tran-
scription during persistent infection and may survive in extrachromosomal or integrated 
forms. Such vDNAs increase RNAi-mediated antiviral response in mosquitoes to boost mos-
quito tolerance to arbovirus infection while establishing persistent infection. In one study, 
Lee et al. detected PCV-specific 21 nucleotide small-RNAs in mosquitoes at different time 
points of infection (2, 6, and 12 days p.i.) as a potential indicator of active viral replication 
in the mosquitoes [99]. These findings complied with other studies where the researchers 
demonstrated the similar phenomenon for other pathogenic mosquito-borne flaviviruses 
(e.g., DENV) and insect-specific flaviviruses (e.g., cell fusing agent viruses). Their presence 
as hot spots suggests that either those are the potential targets of Dicer-2, or are more stable 
or can be reverse-transcribed into vDNA. All these might be the potential cause to enhance 
RNAi antiviral response. However, the authors are also afraid of bias, which could be due to 
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technical issues such as library preparation. In addition to RNAi, piRNAs (piwi RNAs) have 
been reported in mosquitoes and knockdown of piRNAs-related specific proteins indicates 
their endogenous antiviral activity instead of well-established exogenous RNAi activities 
in mosquitoes. Similarly, virus-specific piRNAs with typical A10 bias in sense RNA and U1 bias in antisense RNA have been reported to be produce by Bunya viruses and alphaviruses. 
However, the piRNAs expressed by dengue virus and cell fusing agent virus have only A10 bias in sense RNA. Interestingly, the PCV-specific small RNAs do not show either A10 or U1 
bias features. In this scenario, it is uncertain that either they are piRNAs or just viral degrada-
tion products. This situation is very similar seen in other flavivirus-specific piRNAs, which 
map to very small number of sequences in the genome where the presence of one copy of 
genome indicates more specific targeting than random RNA degradation. The production of 
virus small RNAs and piRNAs through vDNA synthesis is also documented in mosquitoes 
or in their derived cell lines. It is worth mentioning to note the contribution of vDNA in 
the production of small RNAs of virus and piRNAs in mosquitoes, although insect-specific 
viruses like PCV establish persistent infection in their hosts [99].
14. Long intergenic noncoding RNAs (lincRNAs) and their 
association with DENV-host interaction
Considering as another important class of regulatory RNAs, lincRNAs (sometimes known as 
dark matter) have various biological functions including genomic imprinting and cell differ-
entiation specifically in host-pathogen interaction [100]. A growing number of evidences also 
reflect their possible role in gene regulation either epigenetics or nonepigenetics. However, 
their role in immune cell differentiation and activation is poorly understood, but the recent 
discoveries show their potential role in defense system as well as rapid responses to various 
stimuli and stress factors. Some studies also predict their active role to enhance viral replica-
tion or decrease antiviral immunity. It was also depicted that some lincRNAs also interact with 
other noncoding RNAs like miRNAs. The Ae. aegypti-linked lincRNAs are shorter in length 
(approximately 3000 nucleotide bases) than their protein-coding genes. Similarly, their GC 
content was also lower (mean:40.1%) than their protein-coding gene sequences (mean:47.8%). 
However, the AT enrichment or lower GC content is a typical characteristic of lincRNAs and 
congruent with other lincRNAs in other species [100].
Etebari et al. identified lincRNAs in dengue fever vector Ae. aegypti and demonstrated their 
potential role in host antiviral defense [100]. They evaluated lincRNA’s expression in DENV 
serotype 2 (DENV-2) and Wolbachia-infected and noninfected adult mosquitoes as well as 
in Aa20 cells. The findings revealed the increased number of host lincRNAs under the cir-
cumstances of DENV-2 infection, some of which inhibit viral replication in mosquito cells. 
Furthermore, the silencing of only one lincRNA_1317 by RNA interference enhanced the 
viral replication in host cells, which clearly indicates their possible role in host antiviral 
defense. The lincRNA_1317 suppression was confirmed by reverse transcription quantitative 
polymerase chain reaction (RT-qPCR). It was found that the lincRNA_1317 expression was 
increased substantially upon the progression of infection, indicating the possible role of this 
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lincRNA in antiviral defense. The findings might be consistent as the highly overexpressed 
lincRNA_1317 expression (2.33 fold) was reported in Wolbachia-infected mosquitoes as com-
pared to noninfected [100].
The authors also described lincRNAs potential involvement in mosquito-pathogen interac-
tion by determining its association with host-endogenous small RNAs and its direct interac-
tion with DENV-2 infection. lincRNA_1317 was not found to be located in any of the known 
piRNA clusters; however, no differences were found in the mapping pattern and mapped 
read length distribution when reads from DENV-infected and noninfected small RNA librar-
ies were mapped to lincRNA_1317. Gene silencing like role of piRNAs on lincRNA_1317 
transcriptome was also speculated. However, a little information is available about piRNA-
mediated lincRNA although some recent studies predict piRNA-mediated degradation of 
lincRNAs in mouse’s late spermatocytes [100].
The researchers also tested the hypothesis that Ae. aegypti lincRNA_1317 response to micro-
bial challenge could be due to cross regulation between miRNAs and the lincRNAs. For this 
purpose, the normalized minimum free energy (mfe) of hybridization for each Ae. aegypti 
miRNA and lincRNA_1317 was calculated by using RNAhybrid core script. The basic objec-
tive was to identify Ae. aegypti miRNA recognition elements on lincRNA_1317. The results 
were quite interesting as binding sites enrichment for a few miRNAs with more than two 
recognition elements were detected on lincRNA_1317 (e.g., more than four recognition 
sites for miR-278-5p and miR-252-3p were predicted on lincRNA_1317). Furthermore, some 
hot spots for miRNA recognition sites on lincRNA_1317 were also identified, which may 
facilitate multiple miRNAs to bind the same regions. microRNAs contain the capability to 
shake lincRNA stability by targeting their transcripts similar to targeted mRNAs. Similarly, 
lincRNAs possessing multiple recognition sites might act as a competitive inhibitor of 
miRNA by eliminating them to bind their genuine targets by sequestration. The mfe values 
of hybridization for miRNA-lincRNA recognition sites could be a strong predictor of a bind-
ing event between two; however, further investigations and trials are still needed to validate 
this interface [100].
15. IsomiRs and their impact on miRNAs in dengue fever vector  
Ae. aegypti
microRNAs may exist in various lengths and sequence variations, which are known as 
isomiRs [101]. Earlier, those were considered as sequencing errors; however, some studies 
predicted to be physiologically relevant and posttranscriptionally modified miRNA variants. 
IsomiRs may express affinities for different targets than their canonical miRNA counterparts. 
Furthermore, nucleotide heterogeneity could be found at both ends of miRNA sequence in 
the form of nucleotide substitutions despite the variations are more frequent at 3′ end. The 
molecular biology, genome structure, and epigenetics of isomiRs are still poorly understood, 
and the mechanisms of their biogenesis are also considered very complex and even cell-type 
specific. Some variations in miRNA sequences are supposed to be the product of template 
variations, which might be brought by the exonuclease activity of Drosha and Dicer [101].
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It is a well-documented fact that miRNAs may play a vital role to modulate the capability of vec-
tors to propagate the infection for widely damaging arboviruses (e.g., dengue virus) [101]. It has 
been demonstrated that miRNA could be modified in mosquitoes upon the induction of DENV 
infection. As genetic variations in isomiR prevalence have significant impact on gene regulation, 
a clear understanding of the role of isomiR profile of mosquitoes in DENV and other arboviruses 
infection propagation is urgently needed. Etebari et al. in one study found this altered posttran-
scriptional modification role of miRNAs in Ae. aegypti mosquitoes after DENV infection in com-
parison with uninfected mosquitoes. For this purpose, they utilized already published RNA-seq 
data from 2-, 4-, and 9-day DENV-infected and uninfected mosquitoes. The findings showed 
significant variations in miRNA prevalence in response to dengue virus infection although the 
effects were not ubiquitous, and no remarkable alteration in overall pattern of isomiR expression 
was noted upon DENV infection. They calculated the exact/all read count ratio as an index for 
isomiR production rate for all known Ae. aegypti miRNAs. DENV-infected mosquitoes increased 
the isomiR production of 3 miRNAs (miR-2c, miR-210, and miR-34) with notable impact on two 
miRNAs (miR-276 and miR-10) with less read count by DENV infection. The data also demon-
strated that 3 isomiRs of miR-34-5p were also significantly altered by dengue virus infection. 
Collectively, those alterations might have net benefit to determine the mosquito’s role upon 
DENV infection propagation; however, potential biological significances of these modifications 
are still unclear except to infer that some evolutionary function of miRNAs. Similarly, it is also 
ambiguous that why some specific isomiRs potentially modify more in response to DENV infec-
tion in Ae. aegypti. Furthermore, it was also noted that one particular miRNA with significant 
increase in one specific isomiR variants upon DENV infection also contained a common variant 
in at least one other isomiR as well. The authors speculated that establishment and persistence of 
DENV infection might cause significant changes in activity levels of some enzymes involved in 
the production of isomiRs, which ultimately modify the isomiR production frequencies of some 
specific miRNAs. The isomiR production power against different Ae. aegypti miRNAs was also 
demonstrated differently as observed by the read count. The “true” miRNAs were considered 
as those which had an exact match to the canonical sequence (already reported and available 
in miRbase), while the “false” ones were classified as those which significantly differed to that 
reported in miRbase. The authors explicated that in Ae. aegypti, most abundant miRNA sequences 
matched to true miRNAs were just 45%, while 55% miRNAs produced by Ae. aegypti miRNAs 
were false miRNAs, and interestingly, this overall trend was not altered by DENV infection. 
Although the findings are striking and indicate that little variations in miRNA sequences may 
significantly impact target affinities in DENV-host interaction as well as in infection propagation, 
still extensive studies are required in the field to validate such hypothesis [101].
16. Conclusions
An over-growing number of reports and continuous publication of journals and books illus-
trate an intricate interplay between virus-host interactions in dengue fever virus infection. 
Similarly, an increase in morbidity and mortality rate with DENV infection and still unavail-
ability of standard care to treat the infection have diverted the DENV-research to explore new 
paradigms in treatment and to map/identify cellular/molecular pathways to better understand-
ing of disease progression in infected vectors, either mosquitoes or humans. Small interference 
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RNA and microRNA as anti-mRNA-based treatment strategies with strong evidences are 
evolutionary, but unfortunately still not a successful and reliable treatment line in viral infec-
tions with certain issues of drug delivery and long-term therapeutic effects. The involvement 
of lincRNAs and variations in miRNA epigenetic profile in disease-specific arboviruses (e.g., 
dengue virus) during infection also indicate complex genome interactions between virus and 
hosts. RNA association as a novel therapeutic approach to treat infection by gene activation, to 
find out some specific modulators of gene regulation in viral replication as well as in disease 
progression is still in an explanatory phase specifically for disease-specific or insect-specific 
flaviviruses. In conjunction, the molecular approaches to find out disease progression path-
ways in disease-specific arboviruses are still investigative and antiviral treatment approaches 
in the form of siRNAs, microRNAs as well as RNA association still need to be explored fully 
before their practical implementations in diagnostics and as some antiviral therapeutics.
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